Primary |
Anxiety |
25.8% |
Product Used For Unknown Indication |
21.2% |
Bipolar I Disorder |
6.1% |
Depression |
6.1% |
Drug Use For Unknown Indication |
4.5% |
Intentional Self-injury |
4.5% |
Premedication |
4.5% |
Depression Suicidal |
3.0% |
Drug Detoxification |
3.0% |
Insomnia |
3.0% |
Obsessive-compulsive Disorder |
3.0% |
Restlessness |
3.0% |
Analgesic Therapy |
1.5% |
Compulsions |
1.5% |
Drug Withdrawal Syndrome |
1.5% |
Overdose |
1.5% |
Schizophrenia |
1.5% |
Sleep Disorder |
1.5% |
Stress |
1.5% |
Toxicity To Various Agents |
1.5% |
|
Suicide Attempt |
12.2% |
Toxicity To Various Agents |
10.2% |
Intentional Drug Misuse |
8.2% |
Drug Exposure During Pregnancy |
6.1% |
Femur Fracture |
6.1% |
Suicidal Ideation |
6.1% |
Completed Suicide |
4.1% |
Depressed Level Of Consciousness |
4.1% |
Drug Dependence |
4.1% |
Hypertension |
4.1% |
Overdose |
4.1% |
Pulmonary Congestion |
4.1% |
Pulmonary Oedema |
4.1% |
Respiratory Failure |
4.1% |
Somnolence |
4.1% |
Weight Increased |
4.1% |
Withdrawal Syndrome |
4.1% |
Aggression |
2.0% |
Alopecia |
2.0% |
Arrhythmia |
2.0% |
|
Secondary |
Product Used For Unknown Indication |
50.9% |
Drug Use For Unknown Indication |
15.2% |
Suicide Attempt |
3.3% |
Depression |
3.2% |
Hypertension |
3.2% |
Anxiety |
2.7% |
Chronic Obstructive Pulmonary Disease |
2.6% |
Intentional Overdose |
2.2% |
Pain |
2.1% |
Drug Exposure During Pregnancy |
2.0% |
Sedation |
1.9% |
Bipolar I Disorder |
1.5% |
Drug Abuse |
1.4% |
Schizophrenia |
1.2% |
Insomnia |
1.2% |
Foetal Exposure During Pregnancy |
1.1% |
Major Depression |
1.1% |
Sleep Disorder |
1.1% |
Completed Suicide |
1.1% |
Multiple Myeloma |
1.0% |
|
Toxicity To Various Agents |
30.5% |
Suicide Attempt |
11.1% |
Somnolence |
5.7% |
Intentional Overdose |
4.9% |
Vomiting |
4.9% |
Drug Toxicity |
3.8% |
Respiratory Arrest |
3.5% |
Drug Interaction |
3.2% |
Multiple Drug Overdose Intentional |
3.2% |
Sedation |
3.2% |
Overdose |
3.0% |
Serotonin Syndrome |
3.0% |
Syncope |
3.0% |
Toxic Epidermal Necrolysis |
2.7% |
Drug Abuse |
2.4% |
Fall |
2.4% |
Road Traffic Accident |
2.4% |
Tremor |
2.4% |
Weight Increased |
2.4% |
Completed Suicide |
2.2% |
|
Concomitant |
Product Used For Unknown Indication |
28.8% |
Drug Use For Unknown Indication |
20.2% |
Depression |
6.4% |
Hypertension |
6.4% |
Prophylaxis |
5.7% |
Anxiety |
4.9% |
Pain |
4.2% |
Insomnia |
3.4% |
Rheumatoid Arthritis |
3.1% |
Non-small Cell Lung Cancer |
2.3% |
Osteoporosis |
2.2% |
Hiv Infection |
1.8% |
Constipation |
1.7% |
Schizophrenia |
1.6% |
Chronic Obstructive Pulmonary Disease |
1.4% |
Hepatitis C |
1.3% |
Prostate Cancer |
1.2% |
Nausea |
1.2% |
Atrial Fibrillation |
1.1% |
Sleep Disorder |
1.1% |
|
Vomiting |
11.0% |
Weight Decreased |
7.7% |
Weight Increased |
7.4% |
Death |
7.1% |
Pulmonary Embolism |
6.4% |
Pyrexia |
5.7% |
Pneumonia |
5.1% |
Thrombocytopenia |
5.1% |
Hyponatraemia |
4.7% |
Renal Failure |
4.7% |
Tremor |
4.3% |
Suicide Attempt |
4.1% |
Nausea |
3.8% |
White Blood Cell Count Increased |
3.6% |
Syncope |
3.4% |
Urinary Tract Infection |
3.4% |
Suicidal Ideation |
3.3% |
Overdose |
3.1% |
Renal Failure Acute |
3.1% |
Fall |
3.0% |
|
Interacting |
Product Used For Unknown Indication |
38.0% |
Dementia |
13.9% |
Drug Use For Unknown Indication |
7.6% |
Hiv Infection |
7.6% |
Hepatitis C |
5.7% |
Dementia With Lewy Bodies |
5.1% |
Schizoaffective Disorder |
3.8% |
Pain |
3.2% |
Sleep Disorder |
2.5% |
Haemoglobin Decreased |
1.9% |
Abnormal Behaviour |
1.3% |
Generalised Anxiety Disorder |
1.3% |
Mental Disorder |
1.3% |
Oropharyngeal Pain |
1.3% |
Personality Disorder |
1.3% |
Psychotic Disorder |
1.3% |
Tongue Ulceration |
1.3% |
Bk Virus Infection |
0.6% |
Depression |
0.6% |
Drug Dependence |
0.6% |
|
Drug Interaction |
31.4% |
Fall |
8.6% |
Drug Toxicity |
5.7% |
Pulmonary Oedema |
5.7% |
Respiratory Failure |
5.7% |
Vertigo |
5.7% |
Aspiration |
2.9% |
Death |
2.9% |
Discomfort |
2.9% |
Drug Level Increased |
2.9% |
Mania |
2.9% |
Musculoskeletal Pain |
2.9% |
Sedation |
2.9% |
Serotonin Syndrome |
2.9% |
Skin Exfoliation |
2.9% |
Thought Broadcasting |
2.9% |
Toxicity To Various Agents |
2.9% |
Type Iv Hypersensitivity Reaction |
2.9% |
Withdrawal Syndrome |
2.9% |
|